American International Group’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,971
| Closed | -$2.84M | – | 390 |
|
|
2024
Q1 | $2.84M | Sell |
29,971
-257
| -0.9% | -$22K | 0.01% | 901 |
|
|
2023
Q4 | $2.79M | Sell |
30,228
-123
| -0.4% | -$7.97K | 0.01% | 896 |
|
|
2023
Q3 | $1.52M | Buy |
30,351
+1,080
| +4% | +$57.7K | 0.01% | 1041 |
|
|
2023
Q2 | $1.85M | Buy |
29,271
+431
| +1% | +$23.4K | 0.01% | 987 |
|
|
2023
Q1 | $1.3M | Buy |
28,840
+574
| +2% | +$25.9K | 0.01% | 1103 |
|
|
2022
Q4 | $1.24M | Sell |
28,266
-103
| -0.4% | -$4.94K | 0.01% | 1108 |
|
|
2022
Q3 | $1.87M | Buy |
28,369
+401
| +1% | +$25.8K | 0.01% | 957 |
|
|
2022
Q2 | $1.41M | Sell |
27,968
-1,083
| -4% | -$63.4K | 0.01% | 1062 |
|
|
2022
Q1 | $1.86M | Sell |
29,051
-2,045
| -7% | -$147K | 0.01% | 1048 |
|
|
2021
Q4 | $3.33M | Sell |
31,096
-931
| -3% | -$97.4K | 0.02% | 913 |
|
|
2021
Q3 | $3.29M | Sell |
32,027
-761
| -2% | -$70.9K | 0.02% | 902 |
|
|
2021
Q2 | $2.88K | Sell |
32,788
-2,294
| -7% | -$210K | 0.01% | 977 |
|
|
2021
Q1 | $3.41K | Sell |
35,082
-291
| -0.8% | -$29.1K | 0.01% | 936 |
|
|
2020
Q4 | $3.97K | Buy |
35,373
+2,282
| +7% | +$240K | 0.01% | 863 |
|
|
2020
Q3 | $3.07M | Sell |
33,091
-89
| -0.3% | -$6.85K | 0.01% | 845 |
|
|
2020
Q2 | $2.59M | Buy |
33,180
+1,484
| +5% | +$100K | 0.01% | 877 |
|
|
2020
Q1 | $1.85M | Buy |
31,696
+1,117
| +4% | +$71.9K | 0.01% | 904 |
|
|
2019
Q4 | $2.45M | Sell |
30,579
-258
| -0.8% | -$19.3K | 0.01% | 935 |
|
|
2019
Q3 | $2.27M | Sell |
30,837
-214
| -0.7% | -$18.5K | 0.01% | 933 |
|
|
2019
Q2 | $2.93M | Buy |
31,051
+4,684
| +18% | +$387K | 0.01% | 888 |
|
|
2019
Q1 | $2.11M | Sell |
26,367
-855
| -3% | -$63.2K | 0.01% | 982 |
|
|
2018
Q4 | $1.47M | Sell |
27,222
-210
| -0.8% | -$12.8K | 0.01% | 1079 |
|
|
2018
Q3 | $2.14M | Buy |
27,432
+495
| +2% | +$34.4K | 0.01% | 1018 |
|
|
2018
Q2 | $1.71M | Sell |
26,937
-252
| -0.9% | -$20.1K | 0.01% | 1079 |
|
|
2018
Q1 | $2.49M | Sell |
27,189
-1,462
| -5% | -$126K | 0.01% | 924 |
|
|
2017
Q4 | $2.16M | Buy |
28,651
+2,608
| +10% | +$183K | 0.01% | 987 |
|
|
2017
Q3 | $1.81M | Buy |
26,043
+1,947
| +8% | +$104K | 0.01% | 1029 |
|
|
2017
Q2 | $1.22M | Buy |
24,096
+9,368
| +64% | +$398K | ﹤0.01% | 1165 |
|
|
2017
Q1 | $589K | Buy |
14,728
+3,221
| +28% | +$115K | ﹤0.01% | 1490 |
|
|
2016
Q4 | $323K | Sell |
11,507
-30
| -0.3% | -$904 | ﹤0.01% | 1906 |
|
|
2016
Q3 | $343K | Buy |
11,537
+17
| +0.1% | +$422 | ﹤0.01% | 1829 |
|
|
2016
Q2 | $233K | Buy |
11,520
+6,034
| +110% | +$110K | ﹤0.01% | 2036 |
|
|
2016
Q1 | $99K | Hold |
5,486
| – | – | ﹤0.01% | 3435 |
|
|
2015
Q4 | $145K | Sell |
5,486
-10
| -0.2% | -$225 | ﹤0.01% | 3154 |
|
|
2015
Q3 | $117K | Buy |
5,496
+6
| +0.1% | +$166 | ﹤0.01% | 3350 |
|
|
2015
Q2 | $145K | Buy |
+5,490
| New | +$157K | ﹤0.01% | 3329 |
|
Other funds holding BPMC
RSCM
American International Group's BPMC Position: Q2 2024 in Review
American International Group sold out of Blueprint Medicines (BPMC) in Q2 2024, closing a stake of 29,971 shares — an estimated $2.84M sold.
American International Group first reported a position in BPMC in Q2 2015 and held it in 36 quarters. The position peaked at $3.33M in Q4 2021. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.
- American International Group reported no remaining Blueprint Medicines position as of Q2 2024 after selling out during the quarter.
- American International Group sold 29,971 Blueprint Medicines shares in Q2 2024, an estimated $2.84M.
- American International Group first reported a position in Blueprint Medicines in Q2 2015 and held it in 36 quarters.
- American International Group's Blueprint Medicines position peaked at $3.33M in Q4 2021.
- 305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.